FORT LAUDERDALE, Fla. Home Diagnostics and Nipro Diabetes Systems earlier this week announced that the two companies will merge to become Nipro Diagnostics. Both companies are wholly owned by Nipro Corp., which is headquartered in Osaka, Japan.
“Our mission at Home Diagnostics has always been to make high-performance blood glucose monitoring technology more affordable to people with diabetes,” stated Joseph Capper, president of HDI. “Merging with Nipro Diabetes Systems helps us extend this mission to the insulin pump category.”
The name change to Nipro Diagnostics is effective immediately for Home Diagnostics. The merger of the two companies is expected to be completed by the end of the year.